BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Jun 24, 16:00
BioInvent International Profit Margin (Quarterly): -1.31K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.31K% |
| December 31, 2023 | -634.2% |
| September 30, 2023 | -265.3% |
| June 30, 2023 | -674.7% |
| March 31, 2023 | -453.7% |
| December 31, 2022 | -378.5% |
| September 30, 2022 | -356.9% |
| June 30, 2022 | 61.81% |
| March 31, 2022 | -406.7% |
| December 31, 2021 | -1.61K% |
| September 30, 2021 | -2.09K% |
| June 30, 2021 | -1.08K% |
| March 31, 2021 | -1.29K% |
| December 31, 2020 | 28.88% |
| September 30, 2020 | -202.1% |
| June 30, 2020 | -251.4% |
| March 31, 2020 | -195.3% |
| December 31, 2019 | -161.3% |
| September 30, 2019 | -205.6% |
| June 30, 2019 | -99.70% |
| March 31, 2019 | -159.6% |
| December 31, 2018 | -314.9% |
| September 30, 2018 | -317.3% |
| June 30, 2018 | -441.3% |
| March 31, 2018 | -219.8% |
| Date | Value |
|---|---|
| December 31, 2017 | -245.9% |
| September 30, 2017 | -300.1% |
| June 30, 2017 | -206.5% |
| March 31, 2017 | -172.2% |
| December 31, 2016 | -23.66% |
| September 30, 2016 | -3.51K% |
| June 30, 2016 | -262.9% |
| March 31, 2016 | 1.11% |
| December 31, 2015 | -211.3% |
| September 30, 2015 | -1.36K% |
| June 30, 2015 | -689.3% |
| March 31, 2015 | -3.54K% |
| December 31, 2014 | -1.70K% |
| September 30, 2014 | -93.16% |
| June 30, 2014 | 11.45% |
| March 31, 2014 | -1.07K% |
| December 31, 2013 | 40.94% |
| September 30, 2013 | -189.6% |
| June 30, 2013 | -76.78% |
| March 31, 2013 | -122.5% |
| December 31, 2012 | -230.6% |
| September 30, 2012 | -289.0% |
| June 30, 2012 | -1.48K% |
| March 31, 2012 | -253.8% |
| December 31, 2011 | -3.22K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.09K%
Minimum
Sep 2021
61.81%
Maximum
Jun 2022
-578.7%
Average
-367.7%
Median
Profit Margin (Quarterly) Benchmarks
| Abliva AB | -- |
| Karolinska Development AB | 44.16% |
| Calliditas Therapeutics AB | -83.31% |
| Oncopeptides AB | -1.45K% |
| Olink Holding AB | -55.87% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -23.93% |
| Return on Assets | -22.40% |
| Return on Invested Capital | -23.93% |
| Operating Margin (Quarterly) | -1.51K% |
| Return on Net Operating Assets | -192.0% |